Clinical Trial Update: Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy [Phase 2]

View source ↗

Summary

This update reports a Phase 2 trial evaluating the carboplatin, ixabepilone, and cetuximab combination in stage III or IV non-small cell lung cancer patients wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• ERBITUX (cetuximab)
• Ixempra (ixabepilone)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: WITHDRAWN